{"id":"https://openalex.org/W4393096277","doi":"https://doi.org/10.1158/1538-7445.am2024-1962","title":"Abstract 1962: PH009-1, a highly potent, selective and brain-penetrable fourth-generation EGFR-TKI that overcome classic and resistant EGFR mutations in NSCLC","display_name":"Abstract 1962: PH009-1, a highly potent, selective and brain-penetrable fourth-generation EGFR-TKI that overcome classic and resistant EGFR mutations in NSCLC","publication_year":2024,"publication_date":"2024-03-22","ids":{"openalex":"https://openalex.org/W4393096277","doi":"https://doi.org/10.1158/1538-7445.am2024-1962"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2024-1962","doi":"https://doi.org/10.1158/1538-7445.am2024-1962","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.am2024-1962","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102972678","display_name":"Feng Gao","orcid":"https://orcid.org/0000-0001-8391-8279","observed_orcids":["https://orcid.org/0000-0001-8391-8279"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Feng Gao","raw_affiliation_strings":["1Puhe Biopharma, Beijing, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Puhe Biopharma, Beijing, China;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100378537","display_name":"Jing Wang","orcid":"https://orcid.org/0000-0002-5398-0802","observed_orcids":["https://orcid.org/0000-0002-5398-0802","https://orcid.org/0000-0001-5412-9860"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jing Wang","raw_affiliation_strings":["1Puhe Biopharma, Beijing, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Puhe Biopharma, Beijing, China;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100395487","display_name":"Bin Liu","orcid":"https://orcid.org/0000-0002-3168-8456","observed_orcids":["https://orcid.org/0000-0002-3168-8456"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bin Liu","raw_affiliation_strings":["1Puhe Biopharma, Beijing, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Puhe Biopharma, Beijing, China;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101697825","display_name":"Yongyong Wu","orcid":"https://orcid.org/0000-0001-6080-309X","observed_orcids":["https://orcid.org/0000-0001-6080-309X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yongyong Wu","raw_affiliation_strings":["2Gongkang Bio, Suzhou, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Gongkang Bio, Suzhou, China;","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Liandong Jing","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Liandong Jing","raw_affiliation_strings":["2Gongkang Bio, Suzhou, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Gongkang Bio, Suzhou, China;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064166538","display_name":"Pengzhi Zhang","orcid":"https://orcid.org/0000-0001-6920-1490","observed_orcids":["https://orcid.org/0000-0001-6920-1490","https://orcid.org/0009-0003-8865-1173"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pengzhi Zhang","raw_affiliation_strings":["1Puhe Biopharma, Beijing, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Puhe Biopharma, Beijing, China;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089610573","display_name":"Yu Gao","orcid":"https://orcid.org/0000-0002-4210-7338","observed_orcids":["https://orcid.org/0000-0002-4210-7338"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yu Gao","raw_affiliation_strings":["1Puhe Biopharma, Beijing, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Puhe Biopharma, Beijing, China;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100742452","display_name":"Zhizhong Li","orcid":"https://orcid.org/0000-0003-4796-7393","observed_orcids":["https://orcid.org/0000-0003-4796-7393"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zhizhong Li","raw_affiliation_strings":["3Shiyu Children Foundation, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Shiyu Children Foundation, Beijing, China","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5074615062","display_name":"Yongqi Guo","orcid":"https://orcid.org/0000-0001-7698-629X","observed_orcids":["https://orcid.org/0000-0001-7698-629X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yongqi Guo","raw_affiliation_strings":["1Puhe Biopharma, Beijing, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Puhe Biopharma, Beijing, China;","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"84","issue":"6_Supplement","first_page":"1962","last_page":"1962"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/egfr-tyrosine-kinase-inhibitors","display_name":"EGFR tyrosine kinase inhibitors","score":0.8809999823570251},{"id":"https://openalex.org/keywords/fourth-generation-egfr-inhibitors","display_name":"fourth-generation EGFR inhibitors","score":0.8930000066757202},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9800000190734863},{"id":"https://openalex.org/keywords/egfr-mutation","display_name":"EGFR mutation","score":0.8880000114440918},{"id":"https://openalex.org/keywords/egfr-c797s-mutation","display_name":"C797S mutation","score":0.9020000100135803},{"id":"https://openalex.org/keywords/egfr-t790m-mutation","display_name":"T790M mutation","score":0.9240000247955322},{"id":"https://openalex.org/keywords/egfr-l858r-mutation","display_name":"L858R mutation","score":0.7490000128746033},{"id":"https://openalex.org/keywords/acquired-drug-resistance","display_name":"acquired drug resistance","score":0.5989999771118164},{"id":"https://openalex.org/keywords/brain-penetration","display_name":"brain penetration","score":0.8730000257492065},{"id":"https://openalex.org/keywords/osimertinib","display_name":"osimertinib","score":0.7139999866485596},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.8529999852180481},{"id":"https://openalex.org/keywords/pharmacokinetics-pharmacodynamics","display_name":"pharmacokinetics/pharmacodynamics","score":0.7390000224113464},{"id":"https://openalex.org/keywords/systemic-toxicity","display_name":"systemic toxicity","score":0.49000000953674316},{"id":"https://openalex.org/keywords/antitumor-efficacy","display_name":"antitumor efficacy","score":0.5040000081062317}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4998738765716553},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.43168386816978455},{"id":"https://openalex.org/C2778087573","wikidata":"https://www.wikidata.org/wiki/Q418369","display_name":"Erlotinib","level":4,"score":0.4304141104221344},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.3445565104484558},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.32641905546188354},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3207714557647705},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3103523850440979}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2024-1962","doi":"https://doi.org/10.1158/1538-7445.am2024-1962","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.am2024-1962","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4362594234","https://openalex.org/W4393089056","https://openalex.org/W4389241811","https://openalex.org/W3181633741","https://openalex.org/W4282935184","https://openalex.org/W4282933481","https://openalex.org/W7154742223","https://openalex.org/W4391640518","https://openalex.org/W4307909388","https://openalex.org/W3089075100"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Epidermal":[2],"growth":[3,307],"factor":[4],"receptor":[5],"(EGFR)":[6],"inhibitors,":[7],"especially":[8],"3rd":[9,36],"Gen":[10,37,67,88],"inhibitor":[11],"such":[12,94],"as":[13,95,417],"osimertinib":[14],"(Osi),":[15],"have":[16,91,448],"become":[17,451],"the":[18,411,508],"first":[19,458],"line":[20,329,459],"therapy":[21,330,460],"for":[22,179,335,373,457,511],"non-small":[23],"cell":[24,118,152],"lung":[25],"cancer":[26,160],"(NSCLC)":[27],"patients":[28],"with":[29,35,126,177,221,262,279,326,363,368,434,463],"EGFR":[30,38,68,89,121,211,240,309,464,500],"activating":[31],"mutations.":[32,399,465],"However,":[33],"treatments":[34],"inhibitors":[39,90],"lead":[40],"to":[41,81,302,393,450],"occurrence":[42],"of":[43,49,71,184,223,281,297,461,507],"acquired":[44],"C797S":[45],"mutation":[46],"in":[47,115,142,151,173,188,194,289,319,344,349,358,377,502],"10-24%":[48],"patients.":[50],"Though":[51],"studies":[52,148,193],"showed":[53],"that":[54,440,495],"double":[55],"mutations":[56,73,212,501],"19Del/C797S":[57],"(DC)":[58],"and":[59,76,97,111,139,146,196,250,285,308,311,340,423,446,454,491,498],"L858R/C797S":[60],"(LC)":[61],"could":[62],"be":[63],"inhibited":[64,257],"by":[65],"1st":[66],"TKIs,":[69],"appearance":[70],"triple":[72],"19Del/T790M/C797S":[74],"(DTC)":[75],"L858R/T790M/C797S":[77],"(LTC)":[78],"always":[79],"leads":[80],"treatment":[82],"failure.":[83],"In":[84,252,288,323,400,409],"recent":[85],"years,":[86],"4th":[87],"been":[92,101],"developed":[93],"BLU-945":[96,255,345],"PH009-1.":[98,364,435],"PH009-1":[99,178,185,202,293,350,369,441],"had":[100,235],"reported":[102],"on":[103,239,271,305,396,425],"AACR":[104],"annual":[105],"meeting":[106],"2023.":[107],"Methods:":[108],"Cell":[109],"activity":[110,206],"selectivity":[112],"were":[113,149,276,333,356,387],"determined":[114,416],"engineered":[116],"Ba/F3":[117,208,242],"lines":[119],"carrying":[120],"wild":[122],"type":[123],"(WT,":[124],"stimulated":[125],"EGF),":[127],"19Del":[128,327],"(D),":[129],"L858R":[130],"(L),":[131],"19Del/T790M":[132],"(DT),":[133],"L858R/T790M":[134],"(LT),":[135],"DC,":[136,216],"LC,":[137,215,274],"DTC":[138],"LTC.":[140],"The":[141],"vivo":[143,290],"anti-tumor":[144],"efficacy":[145,291],"PK-PD":[147],"performed":[150],"or":[153,158,351],"patient":[154],"derived":[155],"xenograft":[156],"(CDX":[157],"PDX)":[159],"models":[161],"(HCC827,":[162],"D;":[163],"Ba/F3,":[164],"LC;":[165],"PDX,":[166],"DTC).":[167],"Brain":[168],"penetration":[169],"capability":[170],"was":[171,186,314,407,415,432],"tested":[172,321,398,413],"mice":[174,332,367],"orally":[175],"treated":[176,334,366],"7":[180,374],"days.":[181],"Systemic":[182],"safety":[183,430],"evaluated":[187],"28-day":[189],"repeated":[190],"dosing":[191],"toxicity":[192,402,406],"rats":[195],"dogs":[197],"following":[198],"GLP":[199,401],"guidelines.":[200],"Results:":[201],"displayed":[203],"potent":[204,303,453],"anti-proliferation":[205],"against":[207],"cells":[209,243],"harboring":[210],"(L,":[213],"D,":[214,273],"LT,":[217,259],"DT,":[218,258],"LTC,":[219],"DTC)":[220],"IC50":[222,263,280],"2.4,":[224],"1.3,":[225],"5.2,":[226],"1.2,":[227],"1.1,":[228],"1.5,":[229],"2.8,":[230],"1.9":[231],"nM,":[232,267],"respectively,":[233],"but":[234,268,347,361],"very":[236],"weak":[237],"effect":[238],"WT":[241],"(IC50,":[244],"1135":[245],"nM),":[246],"suggesting":[247],"excellent":[248],"potency":[249],"selectivity.":[251],"contrast,":[253],"though":[254],"potently":[256],"DTC,":[260],"LTC":[261],"less":[264],"than":[265,337,389],"5":[266],"its":[269],"activities":[270],"L,":[272],"DC":[275],"not":[277,348,362],"strong":[278],"31.6,":[282],"81.2,":[283],"46.2,":[284],"52.0":[286],"nM.":[287],"studies,":[292,403],"at":[294,316,370,381],"a":[295,452,487],"dose":[296,372,386,414,421],"20":[298],"mg/kg":[299],"BID":[300],"led":[301],"inhibition":[304],"tumor":[306,312,342],"phosphorylation,":[310],"regression":[313],"observed":[315,357],"higher":[317],"doses":[318],"all":[320,397],"models.":[322],"HCC827":[324],"model":[325],"(first":[328],"setting),":[331],"more":[336,388],"200":[338],"days,":[339,375],"one":[341],"relapsed":[343],"group":[346],"Osi":[352,359],"group.":[353],"Also,":[354],"deaths":[355],"group,":[360],"After":[365],"efficacious":[371],"concentrations":[376],"cerebrospinal":[378],"fluids":[379],"(CSF)":[380],"0-8":[382],"h":[383],"post":[384],"final":[385],"enough":[390],"(\u22651.5":[391],"fold)":[392],"cover":[394],"IC80":[395],"no":[404],"unexpected":[405],"observed.":[408],"dogs.":[410],"highest":[412,418],"non-severely":[419],"toxic":[420],"(HNSTD)":[422],"based":[424],"high":[426],"plasma":[427],"exposure,":[428],"wide":[429],"margin":[431],"confirmed":[433],"Conclusion:":[436],"Our":[437],"data":[438],"suggested":[439],"overcome":[442,496],"T790M/C797S":[443],"resistant":[444,499],"mutations,":[445],"also":[447],"potential":[449],"safe":[455],"approach":[456],"NSCLC":[462,503],"Citation":[466],"Format:":[467],"Feng":[468],"Gao,":[469,481],"Jing":[470],"Wang,":[471],"Bin":[472],"Liu,":[473],"Yongyong":[474],"Wu,":[475],"Liandong":[476],"Jing,":[477],"Pengzhi":[478],"Zhang,":[479],"Yu":[480],"Zhizhong":[482],"Li,":[483],"Yongqi":[484],"Guo.":[485],"PH009-1,":[486],"highly":[488],"potent,":[489],"selective":[490],"brain-penetrable":[492],"fourth-generation":[493],"EGFR-TKI":[494],"classic":[497],"[abstract].":[504],"In:":[505],"Proceedings":[506],"American":[509],"Association":[510],"Cancer":[512,530],"Research":[513],"Annual":[514],"Meeting":[515],"2024;":[516],"Part":[517],"1":[518],"(Regular":[519],"Abstracts);":[520],"2024":[521],"Apr":[522],"5-10;":[523],"San":[524],"Diego,":[525],"CA.":[526],"Philadelphia":[527],"(PA):":[528],"AACR;":[529],"Res":[531],"2024;84(6_Suppl):Abstract":[532],"nr":[533],"1962.":[534]},"counts_by_year":[],"updated_date":"2026-10-29T09:56:32.521200","created_date":"2024-03-23T00:00:00"}